Vertex currently operates at the forefront of rare disease scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF), Sickle Cell Disease, Transfusion-Dependent Beta Thalassemia and Pain. In addition to clinical development programs in these commercialized areas, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in Type 1 diabetes, IgA Nephropathy (IgAN), APOL-1 Mediated Kidney Disease, and Duchenne Muscular Dystrophy, among others. The Director, Market Access Strategy (Heme) is accountable for leading, overseeing, and project managing the development of Market Access (MA) strategies, primarily the payer value proposition (PVP) resources and associated materials and trainings, tactical support programs and overall execution of access resources across all channels for the commercialization of CASGEVY. This role requires a significant degree of collaboration, leadership, influencing and driving strategic alignment across multiple functions (Account Management, Trade, Pricing & Contracting, US Public Affairs, HEOR, Global Value & Access Strategy (GVAS), and Marketing). This role will report into the Sr Director, Market Access Strategy, Heme.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Industry
Chemical Manufacturing
Number of Employees
5,001-10,000 employees